Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study

INTRODUCTION: Less than one-third of bladder cancers are non-pure urothelial carcinoma [with variant histological (VH) or non-urothelial carcinoma (non-UC)] for which no treatment guidelines are available. We aim to evaluate the efficacy of systemic treatments in VH or non-UC bladder cancers. MATERI...

Descripción completa

Detalles Bibliográficos
Autores principales: Epaillard, Nicolas, Parent, Pauline, Loriot, Yohann, Lavaud, Pernelle, Vera-Cea, E-B., Martinez-Chanza, Nieves, Rodriguez-Vida, Alejo, Dumont, Clement, Lozano, Rebeca, Llácer, Casilda, Ratta, Raffaele, Oudard, Stephane, Thibault, Constance, Auclin, Edouard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173179/
https://www.ncbi.nlm.nih.gov/pubmed/34094973
http://dx.doi.org/10.3389/fonc.2021.671969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173179/
https://www.ncbi.nlm.nih.gov/pubmed/34094973
http://dx.doi.org/10.3389/fonc.2021.671969

Ejemplares similares